Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
The Lancet Publishing Group
2016
|
| Online Access: | http://hdl.handle.net/20.500.11937/36236 |
| _version_ | 1848754712436801536 |
|---|---|
| author | Chan, Arlene Buyse, M. Yao, B. |
| author_facet | Chan, Arlene Buyse, M. Yao, B. |
| author_sort | Chan, Arlene |
| building | Curtin Institutional Repository |
| collection | Online Access |
| first_indexed | 2025-11-14T08:44:46Z |
| format | Journal Article |
| id | curtin-20.500.11937-36236 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T08:44:46Z |
| publishDate | 2016 |
| publisher | The Lancet Publishing Group |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-362362018-12-14T00:52:21Z Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply Chan, Arlene Buyse, M. Yao, B. 2016 Journal Article http://hdl.handle.net/20.500.11937/36236 10.1016/S1470-2045(16)30018-3 The Lancet Publishing Group restricted |
| spellingShingle | Chan, Arlene Buyse, M. Yao, B. Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply |
| title | Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply |
| title_full | Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply |
| title_fullStr | Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply |
| title_full_unstemmed | Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply |
| title_short | Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply |
| title_sort | neratinib after trastuzumab in patients with her2-positive breast cancer - author's reply |
| url | http://hdl.handle.net/20.500.11937/36236 |